[SRNE] YoY Quarter Result on 31-Dec-2013 [#Q4]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
31-Mar-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- -236.59%
YoY- -543.65%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
Revenue 4,019 1,337 798 101 122 128 512 40.93%
PBT -12,724 -25,413 -10,207 -11,296 -3,236 -3,236 -1,808 38.39%
Tax -701 1,186 1 4 -3,090 -2,474 -1,620 -13.01%
NP -11,957 -23,476 -8,505 -11,296 -1,755 -762 -188 99.66%
Tax Rate - - - - - - - -
Total Cost 15,976 24,813 9,303 11,397 1,877 890 700 68.34%
Ratio Analysis
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
NP Margin -297.51 -1,755.87 -1,065.79 -11,217.68 -1,438.58 -595.84 -36.75 41.65%
Per Share
31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 CAGR
EPS -0.23 -0.62 -0.23 -0.49 -0.14 -0.07 -0.02 50.18%
EPS Diluted -0.23 -0.62 -0.23 -0.49 -0.14 -0.07 -0.02 50.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.